Catalyst Pharmaceuticals, Inc.
NASDAQ:CPRX
Overview | Financials
Company Name | Catalyst Pharmaceuticals, Inc. |
Symbol | CPRX |
Currency | USD |
Price | 21.96 |
Market Cap | 2,606,388,480 |
Dividend Yield | 0% |
52-week-range | 12.27 - 22.27 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Patrick J. McEnany |
Website | https://www.catalystpharma.com |
An error occurred while fetching data.
About Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD